down arrow

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000453
  • SHG: 600613
CNY
9.43
0.18 (1.95%)

Sep 22

SHG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Why is Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. ?

1
Poor Management Efficiency with a low ROCE of 3.19%
  • The company has been able to generate a Return on Capital Employed (avg) of 3.19% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
  • Poor long term growth as Net Sales has grown by an annual rate of -1.35% and Operating profit at 19.07% over the last 5 years
  • The company is Net-Debt Free
  • The company has been able to generate a Return on Equity (avg) of 1.97% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of -1.35% and Operating profit at 19.07% over the last 5 years
4
The company has declared Negative results for the last 3 consecutive quarters
  • NET PROFIT(HY) At CNY 25.25 MM has Grown at -22.76%
  • ROCE(HY) Lowest at 1.19%
  • RAW MATERIAL COST(Y) Grown by 9.81% (YoY)
5
With ROE of 1.52%, it has a fair valuation with a 0.99 Price to Book Value
  • Over the past year, while the stock has generated a return of 41.44%, its profits have fallen by -37.3%
  • At the current price, the company has a high dividend yield of 1.5
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
46.66%
1.23
50.92%
China Shanghai Composite
3.23%
0.23
14.72%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-1.35%
EBIT Growth (5y)
19.07%
EBIT to Interest (avg)
5.91
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
0.80
Tax Ratio
48.66%
Dividend Payout Ratio
97.77%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.98%
ROE (avg)
1.97%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
65
Industry P/E
Price to Book Value
0.99
EV to EBIT
25.09
EV to EBITDA
12.57
EV to Capital Employed
0.98
EV to Sales
0.88
PEG Ratio
NA
Dividend Yield
1.46%
ROCE (Latest)
3.92%
ROE (Latest)
1.52%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

DEBT-EQUITY RATIO (HY)

Lowest at -23.79 %

DEBTORS TURNOVER RATIO(HY)

Highest at 3.47 times

OPERATING PROFIT MARGIN(Q)

Highest at 10.58 %

-12What is not working for the Company
NET PROFIT(HY)

At CNY 25.25 MM has Grown at -22.76%

ROCE(HY)

Lowest at 1.19%

RAW MATERIAL COST(Y)

Grown by 9.81% (YoY

NET SALES(Q)

At CNY 425.19 MM has Fallen at -10.27%

Here's what is working for Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Operating Profit Margin
Highest at 10.58 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Debt-Equity Ratio
Lowest at -23.79 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio
Highest at 3.47 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Net Profit
At CNY 25.25 MM has Grown at -22.76%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is negative

Net Profit (CNY MM)

Net Sales
At CNY 425.19 MM has Fallen at -10.27%
over average net sales of the previous four periods of CNY 473.85 MM
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Raw Material Cost
Grown by 9.81% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Footer loading